Ascentage Pharma Group International AAPG
NASDAQ AAPG
$15.05 -0.64 (-4.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ascentage Pharma Group International (AAPG) Accumulated Expenses (2023 - 2025)

Updated

Ascentage Pharma Group International's Accumulated Expenses came in at $106.76 million for Q4 2025, down 13.8% from $123.82 million a year earlier.

Analysis

Ascentage Pharma Group International (AAPG) Accumulated Expenses (2023 - 2025) Analysis & Trends

At the end of FY2025, Ascentage Pharma Group International's Accumulated Expenses was $108.28 million, down 11.1% from FY2024.

  • Going back by year, Accumulated Expenses was $121.85 million in FY2024 (-27.0%) and $166.86 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Ascentage Pharma Group International 1.46 Bn 432.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 106.76 Mn
Dec 31, 2024 123.82 Mn
Dec 31, 2023 163.77 Mn
API Access

Ascentage Pharma Group International Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AAPG&period=max&api_key=YOUR_API_KEY